These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 14624182

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [Abstract] [Full Text] [Related]

  • 23. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
    Kok RM, Nolen WA, Heeren TJ.
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
    [Abstract] [Full Text] [Related]

  • 24. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
    Miljković BR, Pokrajac M, Timotijević I, Varagić V.
    Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 29. Placebo response and antidepressant response.
    Alexopoulos GS, Kanellopoulos D, Murphy C, Gunning-Dixon F, Katz R, Heo M.
    Am J Geriatr Psychiatry; 2007 Feb; 15(2):149-58. PubMed ID: 17272735
    [Abstract] [Full Text] [Related]

  • 30. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U, Onder E.
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [Abstract] [Full Text] [Related]

  • 31. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
    Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S.
    Psychiatry Res; 2009 Sep 30; 169(2):132-8. PubMed ID: 19709754
    [Abstract] [Full Text] [Related]

  • 32. The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients.
    Suzuki Y, Sawamura K, Someya T.
    Pharmacogenomics J; 2004 Sep 30; 4(4):283-6. PubMed ID: 15148501
    [Abstract] [Full Text] [Related]

  • 33. Patterns of symptom improvement during antidepressant treatment of delusional depression.
    Serretti A, Lattuada E, Zanardi R, Franchini L, Smeraldi E.
    Psychiatry Res; 2000 May 15; 94(2):185-90. PubMed ID: 10808044
    [Abstract] [Full Text] [Related]

  • 34. Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysis.
    Fu AZ, Christensen DB, Hansen RA, Liu GG.
    Clin Ther; 2006 Jun 15; 28(6):979-89. PubMed ID: 16860180
    [Abstract] [Full Text] [Related]

  • 35. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
    Colonna L, Andersen HF, Reines EH.
    Curr Med Res Opin; 2005 Oct 15; 21(10):1659-68. PubMed ID: 16238906
    [Abstract] [Full Text] [Related]

  • 36. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep 15; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 37. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C, Olivieri L, Di Loreto G, Dionisio P.
    Curr Med Res Opin; 2006 Sep 15; 22(9):1703-13. PubMed ID: 16968574
    [Abstract] [Full Text] [Related]

  • 38. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan 15; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 39. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.
    Curr Med Res Opin; 2006 Jul 15; 22(7):1331-41. PubMed ID: 16834832
    [Abstract] [Full Text] [Related]

  • 40. Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients.
    Thornett AM, Mynors-Wallis LM.
    Med Sci Monit; 2002 Mar 15; 8(3):CR193-6. PubMed ID: 11887035
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.